It was shown that HER2 overexpression waspresent in 20% of BC patients and associated with poor prognosis.40 In our study, all (n = 3) BRCA2 and 1 of 2 BRCA1 pathogenic variantcarriers had HER2 overexpression. This evidence concerns the gene BRCA2 and breast cancer.